Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Nicklin

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loopAngelika B Kritz, Campbell G Nicol, Kate L Dishart, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectorsJenny A Greig, Suzanne Mk Buckley, Simon N Waddington, et al.
Viruses|August 28, 2021
In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic ApplicationsEmily A Bates, John R Counsell, Sophie Alizert, et al.
Journal of Molecular and Cellular Cardiology|June 24, 2003
Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapyKate L Dishart, Laura Denby, Sarah J George, et al.
Journal of Virology|October 24, 2008
Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transferAlan L Parker, Simon N Waddington, Suzanne M K Buckley, et al.
Pharmacological Reviews|June 4, 2026
Vein graft failure: Pathophysiology, detection, prevention and emerging therapeutic strategiesSimon D Brown, Sandra Sanchez-Esteban, Laura Clark, et al.
Blood|May 12, 2009
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transferRaul Alba, Angela C Bradshaw, Alan L Parker, et al.
Hypertension (Dallas, Tex. : 1979)|February 18, 2009
Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2Rachel Masson, Stuart A Nicklin, Margaret Anne Craig, et al.
Blood|June 22, 2006
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytesAlan L Parker, Simon N Waddington, Campbell G Nicol, et al.
Journal of the American College of Cardiology|December 17, 2016
Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial InfarctionCaroline Fattah, Katrin Nather, Charlotte S McCarroll, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loopAngelika B Kritz, Campbell G Nicol, Kate L Dishart, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectorsJenny A Greig, Suzanne Mk Buckley, Simon N Waddington, et al.
Viruses|August 28, 2021
In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic ApplicationsEmily A Bates, John R Counsell, Sophie Alizert, et al.
Journal of Molecular and Cellular Cardiology|June 24, 2003
Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapyKate L Dishart, Laura Denby, Sarah J George, et al.
Journal of Virology|October 24, 2008
Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transferAlan L Parker, Simon N Waddington, Suzanne M K Buckley, et al.
Pharmacological Reviews|June 4, 2026
Vein graft failure: Pathophysiology, detection, prevention and emerging therapeutic strategiesSimon D Brown, Sandra Sanchez-Esteban, Laura Clark, et al.
Blood|May 12, 2009
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transferRaul Alba, Angela C Bradshaw, Alan L Parker, et al.
Hypertension (Dallas, Tex. : 1979)|February 18, 2009
Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2Rachel Masson, Stuart A Nicklin, Margaret Anne Craig, et al.
Blood|June 22, 2006
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytesAlan L Parker, Simon N Waddington, Campbell G Nicol, et al.
Journal of the American College of Cardiology|December 17, 2016
Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial InfarctionCaroline Fattah, Katrin Nather, Charlotte S McCarroll, et al.
Pageof 8